遺傳基因面板市場:各技術，設計，用途，終端用戶，地區 - 規模，佔有率，展望，機會分析(2022年～2028年)

遺傳基因面板市場，由於在遺傳性疾病診斷為使用遺傳基因面板的臨床試驗實施預計促進在預測期間內的成長。

本報告提供全球遺傳基因面板市場相關調查，市場動態，COVID-19影響，各市場區隔、地區的市場分析，競爭情形，主要企業的簡介等資訊。

目錄

第1章 調查目的、前提條件

第2章 市場概要

• 報告概要
• 摘要整理
• Coherent Opportunity Map(COM)

第3章 市場動態，法規，及趨勢分析

• 市場動態
  • 促進因素
  • 阻礙因素
  • 市場機會
• 影響分析
• 波特的五力分析
• 產業趨勢
• 開發平台分析
• 主要的焦點
• 流行病學
• 價格分析
• 償付情境
• 法規情境
• 全球供應鏈分析

第4章 COVID-19影響分析

• COVID-19流行病學
• COVID-19對遺傳基因面板的需求與供給的影響
• COVID-19對遺傳基因面板市場的影響

第5章 全球遺傳基因面板市場:各技術(2017年～2028年，金額)

• 簡介
• 擴增子為基礎
• 雜合反應為基礎

第6章 全球遺傳基因面板市場:各設計(2017年～2028年，金額)

• 簡介
• 事前設計遺傳基因面板
• 客製化遺傳基因面板

第7章 全球遺傳基因面板市場:各用途(2017年～2028年，金額)

• 簡介
• 藥物遺傳學
• 先天性障礙的診斷
• 癌症風險評估
• 其他

第8章 全球遺傳基因面板市場:各終端用戶(2017年～2028年，金額)

• 簡介
• 研究、學術機構
• 醫院、診斷實驗室
• 生物科技、製藥公司

第9章 全球遺傳基因面板市場:各地區(2017年～2028年，金額)

• 簡介
• 北美
• 南美
• 歐洲
• 亞太地區
• 中東
• 非洲

第10章 競爭情形

• 企業簡介
  • Thermo Fisher Scientific Inc.
  • BGI
  • GENEWIZ, Inc.
  • GATC Biotech
  • Novogene Co., Ltd.
  • QIAGEN
  • Integrated DNA Technologies, Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd
  • Personalis Inc.
  • GeneDx Inc.
  • Invitae Corporation
• 分析師的見解

第11章 Section

Gene panels are specialized diagnostic tools used to assess multiple genes at once for mutations related to diseases such as cancer, cardiomyopathy, and others. Gene panels enable the users to obtain results at a reduced cost and time. Gene panels are useful in sequencing genes such as BRCA1 to detect mutations that may lead to cancer. DNA sample from blood, muscle or saliva can be used in gene panel testing. Low muscle tone, epilepsy, and short stature are few conditions which can be diagnosed using gene panel tests. Rapid research in DNA sequencing technology has led to the advancement of gene panels making them more efficient, economical, and flexible.

Market Dynamics

Market players are conducting clinical trials for exploring the potential uses of gene panels for diagnosis of a number of genetic disorders, which could contribute to the growth of the gene panel market over the forecast period. For instance, in November 2021 Bordeaux University Hospital, France, initiated an observational clinical study for implementation of a next generation sequencing gene panel for diagnosis of incomplete forms of albinism. This study identifies the usability of NGS gene panel in overcoming the challenges faced in identification of ocular albinism as it does not show many observable ophthalmic signs. This study comprises of 100 participants and is expected to be completed by March 2022.

Market players are focusing on launch of products, which is expected to strengthen their position in the global gene panel market. For instance, in June 2018, Thermo Fisher Scientific Inc., an American scientific instrumentation company, launched Ion AmpliSeq HD technology as an amplicon-based library for targeted next gene sequencing, it enables the user to customize one's own gene panel by selecting the appropriate gene sequences from the gene library which are associated with a particular disease and detect low-frequency alleles in tumor RNA or DNA.

Key features of the study:

• This report provides an in-depth analysis of global gene panel market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market

• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players

• It profiles leading players in the global gene panel market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans

• Key companies covered as a part of this study include Thermo Fisher Scientific Inc., BGI, GENEWIZ, Inc., GATC Biotech, Novogene Co., Ltd., QIAGEN, Integrated DNA Technologies, Inc., Illumina Inc., Agilent Technologies, Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd, Personalis Inc., GeneDx Inc., and Invitae Corporation

• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics

• The global gene panel market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts

• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the gene panel market

Detailed Segmentation:

• Global Gene Panel Market, By Technique:
  • Amplicon-Based
  • Hybridization-Based
• Global Gene Panel Market, By Design:
  • Predesigned Gene Panels
  • Customized Gene Panels
• Global Gene Panel Market, By Application:
  • Pharmacogenetics
  • Diagnosis of Congenital Disorders
  • Cancer Risk Assessment
  • Others
• Global Gene Panel Market, By End User:
  • Research and Academic Institutes
  • Hospital and Diagnostic Laboratories
  • Biotechnology and Pharmaceutical Companies
• Global Gene Panel Market, By Region:
  • North America
• By Technique:
  • Amplicon-Based
  • Hybridization-Based
• By Design:
  • Predesigned Gene Panels
  • Customized Gene Panels
• By Application:
  • Pharmacogenetics
  • Diagnosis of Congenital Disorders
  • Cancer Risk Assessment
  • Others
• By End User:
  • Research and Academic Institutes
  • Hospital and Diagnostic Laboratories
  • Biotechnology and Pharmaceutical Companies
• By Country:
  • U.S.
  • Canada
  • Latin America
• By Technique:
  • Amplicon-Based
  • Hybridization-Based
• By Design:
  • Predesigned Gene Panels
  • Customized Gene Panels
• By Application:
  • Pharmacogenetics
  • Diagnosis of Congenital Disorders
  • Cancer Risk Assessment
  • Others
• By End User:
  • Research and Academic Institutes
  • Hospital and Diagnostic Laboratories
  • Biotechnology and Pharmaceutical Companies
• By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
• By Technique:
  • Amplicon-Based
  • Hybridization-Based
• By Design:
  • Predesigned Gene Panels
  • Customized Gene Panels
• By Application:
  • Pharmacogenetics
  • Diagnosis of Congenital Disorders
  • Cancer Risk Assessment
  • Others
• By End User:
  • Research and Academic Institutes
  • Hospital and Diagnostic Laboratories
  • Biotechnology and Pharmaceutical Companies
• By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • Asia Pacific
• By Technique:
  • Amplicon-Based
  • Hybridization-Based
• By Design:
  • Predesigned Gene Panels
  • Customized Gene Panels
• By Application:
  • Pharmacogenetics
  • Diagnosis of Congenital Disorders
  • Cancer Risk Assessment
  • Others
• By End User:
  • Research and Academic Institutes
  • Hospital and Diagnostic Laboratories
  • Biotechnology and Pharmaceutical Companies
• By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
• By Technique:
  • Amplicon-Based
  • Hybridization-Based
• By Design:
  • Predesigned Gene Panels
  • Customized Gene Panels
• By Application:
  • Pharmacogenetics
  • Diagnosis of Congenital Disorders
  • Cancer Risk Assessment
  • Others
• By End User:
  • Research and Academic Institutes
  • Hospital and Diagnostic Laboratories
  • Biotechnology and Pharmaceutical Companies
• By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
• By Technique:
  • Amplicon-Based
  • Hybridization-Based
• By Design:
  • Predesigned Gene Panels
  • Customized Gene Panels
• By Application:
  • Pharmacogenetics
  • Diagnosis of Congenital Disorders
  • Cancer Risk Assessment
  • Others
• By End User:
  • Research and Academic Institutes
  • Hospital and Diagnostic Laboratories
  • Biotechnology and Pharmaceutical Companies
• By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
• Thermo Fisher Scientific Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
• BGI
• GENEWIZ, Inc.
• GATC Biotech
• Novogene Co., Ltd.
• QIAGEN
• Integrated DNA Technologies, Inc.
• Illumina, Inc.
• Agilent Technologies, Inc.
• Eurofins Scientific
• F. Hoffmann-La Roche Ltd
• Personalis Inc.
• GeneDx Inc.
• Invitae Corporation

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Technique
  • Market Snippet, By Design
  • Market Snippet, By Application
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Porter's Analysis
• Industry Trends
• Pipeline Analysis
• Key Highlights
• Epidemiology
• Pricing Analysis
• Reimbursement Scenario
• Regulatory Scenario
• Global Supply Chain Analysis

4. COVID - 19 Impact Analysis

• COVID-19 Epidemiology
• Impact of COVID-19 on Demand and Supply of Gene Panel
• Impact of Covid-19 on the Gene Panel Market

5. Global Gene Panel Market, By Technique, 2017-2028 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Amplicon-Based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Hybridization-Based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Gene Panel Market, By Design, 2017 - 2028 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Predesigned Gene Panels
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Customized Gene Panels
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Gene Panel Market, By Application, 2017 - 2028 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Pharmacogenetics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Diagnosis of Congenital Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Cancer Risk Assessment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Global Gene Panel Market, By End User, 2017 - 2028 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Research and Academic Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Hospital and Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Biotechnology and Pharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

9. Global Gene Panel Market, By Region, 2017 - 2028 (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
  • Regional Trends
• North America
  • Market Size and Forecast, By Technique, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Design, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • U.S.
  • Canada
• Latin America
  • Market Size and Forecast, By Technique, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Design, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Market Size and Forecast, By Technique, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Design, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Technique, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Design, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • Market Size and Forecast, By Technique, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Design, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Market Size and Forecast, By Technique, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Design, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

10. Competitive Landscape

• Company Profiles
  • Thermo Fisher Scientific Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • BGI
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • GENEWIZ, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • GATC Biotech
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Novogene Co., Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • QIAGEN
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Integrated DNA Technologies, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Illumina, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Agilent Technologies, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Eurofins Scientific
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • F. Hoffmann-La Roche Ltd
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Personalis Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • GeneDx Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Invitae Corporation
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
• Analyst Views

11. Section

• References
• Research Methodology
• About us and Sales Contact